On Demand Education organized by MLS credit categories.
Ann Moyer, M.D., Ph.D., discusses an additional gene, NUDT15, which is important in the prediction of thiopurine-related toxicity This gene has been added to our TPMT genotyping assay available through Mayo Medical Laboratories.
New Tests Launched in August - Insights
In August 2017, Mayo Medical Laboratories announced a new test along with numerous reference value changes, obsolete tests, and algorithm changes.
New Tests Launched in February - Insights
In February 2018, Mayo Medical Laboratories announced two new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Lymphomas Testing - Mayo Clinic Laboratories
To assist clinicians with lymphoma diagnosis, Mayo Clinic has a highly experienced, 9-member hematopathology section focusing on lymphoma diagnosis, which diagnoses more than 3,000 lymphoma cases per year.
TPMT Testing in Treatment of Inflammatory Bowel Disease [Test in Focus] - Insights
Detection of individuals with low thiopurine methyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.
Mayo Clinic Laboratory and Pathology Research Roundup: January 9 - Insights
This week's research roundup feature: To describe a 41-year-old woman with a history of neonatal onset multisystem inflammatory disease, on treatment with daily subcutaneous injections of 600 mg of recombinant interleukin-1 receptor...
Ethical Issues in Phlebotomy - Insights
This "Phlebotomy webinar" will discuss ethical issues frequently faced by phlebotomists.
Mayo Clinic Laboratory and Pathology Research Roundup: Dec. 3 - Insights
This week’s Research Roundup highlights predicting renal function outcomes after partial and radical nephrectomy.
Mayo Clinic Laboratory and pathology research roundup: April 11 - Insights
This week's Research Roundup feature: A stress-induced cilium-to-PML-NB route drives senescence initiation.